CLINICAL_TRIALS
trial_result
· 2012-06-08
Clinical Trial Update: A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes [Phase 1]
Summary
Phase 1 multiple ascending dose study of CAT-1004 in patients with Type 2 diabetes to evaluate safety, tolerability, and pharmacokinetics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catabasis Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED